Modeling Peptide–Protein Interactions by a Logo-Based Method: Application in Peptide–HLA Binding Predictions

Irini Doytchinova,Mariyana Atanasova,Antonio Fernandez,F. Javier Moreno,Frits Koning,Ivan Dimitrov
DOI: https://doi.org/10.3390/molecules29020284
IF: 4.6
2024-01-06
Molecules
Abstract:Peptide–protein interactions form a cornerstone in molecular biology, governing cellular signaling, structure, and enzymatic activities in living organisms. Improving computational models and experimental techniques to describe and predict these interactions remains an ongoing area of research. Here, we present a computational method for peptide–protein interactions' description and prediction based on leveraged amino acid frequencies within specific binding cores. Utilizing normalized frequencies, we construct quantitative matrices (QMs), termed 'logo models' derived from sequence logos. The method was developed to predict peptide binding to HLA-DQ2.5 and HLA-DQ8.1 proteins associated with susceptibility to celiac disease. The models were validated by more than 17,000 peptides demonstrating their efficacy in discriminating between binding and non-binding peptides. The logo method could be applied to diverse peptide–protein interactions, offering a versatile tool for predictive analysis in molecular binding studies.
chemistry, multidisciplinary,biochemistry & molecular biology
What problem does this paper attempt to address?
The problem this paper attempts to address is the development of a new computational method to predict peptide-protein interactions, specifically for peptide binding predictions related to HLA-DQ2.5 and HLA-DQ8.1 proteins associated with celiac disease. Specifically, the paper proposes a method based on sequence logos to describe and predict peptide-protein interactions and validates the effectiveness of this method through extensive external test sets. This method can be applied to a wide range of peptide-protein interaction studies, providing a general analytical tool for molecular binding research. Additionally, the method can identify whether a peptide binds to HLA-DQ2.5 or HLA-DQ8.1, which is significant for assessing whether novel proteins might trigger celiac disease.